Revance(RVNC) Prnewswire·2025-02-24 10:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Revance Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and material breaches of agreements during a specified class period [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from February 29, 2024, to December 6, 2024 [1]. - Allegations include that Revance was in material breach of the Distribution Agreement with Teoxane, which granted Revance exclusive rights to import, market, promote, sell, and distribute Teoxane's dermal fillers [1]. - The breach allegedly increased the risk of litigation and monetary and reputational harm to the company [1]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action and can do so without any cost or obligation [2]. - The deadline for shareholders to seek lead plaintiff status is March 4, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [3].